Advisors Management Group Inc. ADV Sells 39,525 Shares of Pfizer Inc. $PFE

robot
Abstract generation in progress

Advisors Management Group Inc. ADV reduced its stake in Pfizer Inc. by 21.0% in Q4, selling 39,525 shares and retaining 148,395 shares valued at $3.695 million. Analyst opinions on Pfizer are mixed, with a consensus “Hold” rating and a target price of $28.19, despite recent Q4 earnings beating estimates. The stock is currently trading near $27.03, with recent news highlighting both positive clinical pipeline developments and concerns over political risks and dividend sustainability.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin